SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis. Efe C, Tascilar K, Gerussi A, Bolis F, et al. J Autoimmun 2022;132:102906.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Efe C, Tascilar K, Gerussi A, Bolis F, et al. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis. J Autoimmun 2022;132:102906.
PMID: 36088883